Zobrazeno 1 - 10
of 599
pro vyhledávání: '"Ravi Retnakaran"'
Autor:
Caroline K. Kramer, Chang Ye, Anthony J Hanley, Philip W Connelly, Mathew Sermer, Bernard Zinman, Ravi Retnakaran
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background The cumulative effect of postpartum weight retention from each pregnancy in a woman’s life may contribute to her risk of ultimately developing type 2 diabetes and cardiovascular disease. However, there is limited direct evidence
Externí odkaz:
https://doaj.org/article/9fddcb9bdfe445db8125bdfe4174abc3
Autor:
Ryan V. Chieu, Katharine Hamilton, Paul M. Ryan, Julia Copeland, Pauline W. Wang, Ravi Retnakaran, David S. Guttman, John Parkinson, Jill K. Hamilton
Publikováno v:
Gut Microbes, Vol 16, Iss 1 (2024)
ABSTRACTGestational diabetes mellitus (GDM) is a metabolic complication that manifests as hyperglycemia during the later stages of pregnancy. In high resource settings, careful management of GDM limits risk to the pregnancy, and hyperglycemia typical
Externí odkaz:
https://doaj.org/article/65f0f11ff4704dc282763e3a49f517ea
Autor:
Ravi Retnakaran, Jiajie Pu, Alexandra Emery, Stewart B. Harris, Sonja M. Reichert, Hertzel C. Gerstein, Natalia McInnes, Caroline K. Kramer, Bernard Zinman
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-9 (2023)
Abstract In early type 2 diabetes, the strategy of “induction” with short-term intensive insulin therapy followed by “maintenance” with metformin can stabilize pancreatic beta-cell function in some patients but not others. We thus sought to e
Externí odkaz:
https://doaj.org/article/e3a835b9ff674d92b82a327d74cb77f2
Autor:
Brandy Wicklow, Ravi Retnakaran
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 3, Pp 333-344 (2023)
Gestational diabetes mellitus (GDM) has historically been perceived as a medical complication of pregnancy that also serves as a harbinger of maternal risk of developing type 2 diabetes mellitus (T2DM) in the future. In recent decades, a growing body
Externí odkaz:
https://doaj.org/article/0cefa7fbf6124946b6f750df90b4ea80
Autor:
Ravi Retnakaran, Jiajie Pu, Anthony J. Hanley, Philip W. Connelly, Mathew Sermer, Bernard Zinman
Publikováno v:
EClinicalMedicine, Vol 67, Iss , Pp 102363- (2024)
Summary: Background: The cardiometabolic implications of postprandial hyperinsulinemia are unclear with recent studies suggesting both adverse and beneficial associations. We aimed to evaluate the longitudinal cardiometabolic implications of the post
Externí odkaz:
https://doaj.org/article/7a7ac74a2e2947008c039d6f067c7af3
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-7 (2023)
Abstract Objective Basal insulin glargine has a neutral effect on cardiovascular risk in type 2 diabetes (T2DM). In practice, basal insulin is often paired with a glucagon-like peptide-1 receptor agonist (GLP1-RA) or meal insulin; however, the cardio
Externí odkaz:
https://doaj.org/article/4ecf81471f384908b1c5fc0601dbfc9a
Autor:
Jingfen Chen, Xiaolu Lai, Lepeng Zhou, Ravi Retnakaran, Shi Wu Wen, Daniel Krewski, Liping Huang, Meng Li, Ri-hua Xie
Publikováno v:
International Breastfeeding Journal, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background Research on the association between breastfeeding and postpartum post-traumatic stress disorder (PTSD) is sparse. This study aimed to examine the association between exclusive breastfeeding up to 42 days after childbirth and postp
Externí odkaz:
https://doaj.org/article/f764e5a6d7b54e5390cd16a5b0626616
Autor:
Ravi Retnakaran, Baiju R. Shah
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Women with gestational diabetes (GDM) have an elevated lifetime incidence of cardiovascular disease (CVD), but the basis of this excess risk remains to be established. In this context, we hypothesized that chronic exposure to adve
Externí odkaz:
https://doaj.org/article/603ee121eca74fc88c148b7327df14d1
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-5 (2022)
Abstract In clinical research, weight measurement in first trimester is often treated as a surrogate for pre-pregnancy weight. The validity of this critical assumption, however, is uncertain. Thus, we sought to prospectively evaluate the relationship
Externí odkaz:
https://doaj.org/article/ad07a29fe7144dbe9a1126f41d9a6011
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Combining a GLP-1 receptor agonist, to increase endogenous beta cell function, with exogenous insulin is a possible therapeutic option for the treatment of type 2 diabetes. Here, the authors show adding exenatide to basal insulin in early type 2 diab
Externí odkaz:
https://doaj.org/article/7dfbcc22d4e74f62a30ad39bc6fd1bfb